CHEMBIO DIAGNOSTICS INC's ticker is CEMI and the CUSIP is 163572209. A total of 62 filers reported holding CHEMBIO DIAGNOSTICS INC in Q3 2020. The put-call ratio across all filers is 0.99 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $250,000 | – | 76,893 | – | 0.19% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACUTA CAPITAL PARTNERS, LLC | 2,006,667 | $16,053,000 | 2.62% |
ARS Investment Partners, LLC | 860,002 | $6,880,000 | 0.84% |
Gagnon Advisors, LLC | 129,573 | $1,037,000 | 0.77% |
GAGNON SECURITIES LLC | 201,698 | $1,614,000 | 0.58% |
PERKINS CAPITAL MANAGEMENT INC | 74,500 | $596,000 | 0.54% |
Benchmark Capital Advisors | 75,092 | $601,000 | 0.48% |
Cortina Asset Management, LLC | 524,388 | $4,195,000 | 0.21% |
Whitegate Investment Counselors, Inc. | 11,000 | $88,000 | 0.02% |
Phocas Financial Corp. | 20,000 | $160,000 | 0.01% |
ROYCE & ASSOCIATES LP | 215,353 | $1,723,000 | 0.01% |